Current and future challenges in quality assurance in molecular diagnostics.

dc.contributor.authorAhmad-Nejad, Parviz
dc.contributor.authorAshavaid, Tester
dc.contributor.authorVacaflores Salinas, Aldo
dc.contributor.authorHuggett, Jim
dc.contributor.authorHarris, Kathryn
dc.contributor.authorLinder, Mark W
dc.contributor.authorBaluchova, Katarina
dc.contributor.authorSteimer, Werner
dc.contributor.authorPayne, Deborah A
dc.coverage.spatialBolivia
dc.date.accessioned2026-03-24T15:04:10Z
dc.date.available2026-03-24T15:04:10Z
dc.date.issued2021
dc.descriptionVol. 519, pp. 239-246
dc.description.abstractThe development and performance of molecular genetic assays has required increasingly complex quality assurance in recent years and continues to pose new challenges. Quality management officers, as well as academic and technical personnel are confronted with new molecular genetic parameters, methods, changing regulatory environments, questions regarding appropriate validation, and quality control for these innovative assays that are increasingly applying quantification and/or multiplex formats. Yet, quality assurance and quality control guidelines are still not widely available or in some circumstances have become outdated. For these reasons, the need for solutions to provide test confidence continues to grow. In order to integrate new test procedures into existing quality assurance measures, the ISO 15189 guideline can serve as an orientation. The ISO 15189 guideline describes requirements for medical laboratories and thus includes those performing molecular diagnostics. This article gives an overview of the possibilities and challenges in quality assurance of molecular parameters and shows possible solutions.eng
dc.description.sponsorshipInstitute for Medicine Laboratory Diagnostics, Centre for Clinical and Translational Research (CCTR), HELIOS University Hospital, Wuppertal, Witten/Herdecke University, Germany. Electronic address: parviz.ahmad-nejad@helios-gesundheit.de. | Department of Laboratory Medicine, P.D. Hinduja National Hospital and Medical Research Center, Mumbai, India. | Plexus Laboratorio, La Paz, Bolivia.
dc.identifier.doi10.1016/j.cca.2021.05.004
dc.identifier.issn1873-3492
dc.identifier.otherPMID:33971158
dc.identifier.urihttps://doi.org/10.1016/j.cca.2021.05.004
dc.identifier.urihttps://andeanlibrary.org/handle/123456789/101017
dc.language.isoeng
dc.relation.ispartofClinica chimica acta; international journal of clinical chemistry
dc.sourcePubMed
dc.subjectDNA
dc.subjectExternal quality assurance
dc.subjectQuality control
dc.titleCurrent and future challenges in quality assurance in molecular diagnostics.
dc.typeArtículo Científico Publicado

Files